Patent ID: 7329685

Claim:
A compound of formula (I): wherein: R 1 represents a group selected from: each ring of which optionally includes a further heteroatom N, Z represents an optional substituent halogen, alk represents alkylene or alkenylene, T represents S, O or NH; R 2 represents —C 1-6 alkyl, —C 1-3 alkylCN, —C 0-3 alkylR c , —C 1-3 alkylR f , —C 2-3 alkylNR a R b , —C 2-3 alkylOC 1-6 alkyl, —C 2-3 alkylOC 1-3 alkylCONR a R b , with the proviso that R 2 does not represent C 2-3 alkylmorpholino; R a and R b independently represent hydrogen, or —C 1-6 alkyl; R c represents —C 3-6 cycloalkyl; R f represents phenyl or a 5- or 6-membered aromatic heterocyclic ring, containing at least one heteroatom selected from O, N(O) m or S(O) n , optionally substituted by 0 to 2 groups selected from —C 1-4 alkyl or —NH 2 ; n represents 0-2; m represents 0 or 1; X represents phenyl or a 5- or 6-membered aromatic heterocyclic group containing at least one heteroatom selected from O, N or S, each of which is optionally substituted by 0-2 groups selected from: halogen, —C 1-4 alkyl, —C 2-4 alkenyl, —CN, —CF 3 , —NR a R b , —C 0-4 alkylOR e , —C(O)R d and —C(O)NR a R b ; R e represents hydrogen or —C 1-6 alkyl; Y represents a substituent selected from hydrogen, halogen, —C 1-4 alkyl, —C 2-4 alkenyl, —NR a R b , —NO 2 , —C(O)NR a R b , —N(C 1-4 alkyl)(CHO), —NHCOC 1-4 alkyl, —NHSO 2 R d , —C 0-4 alkylOR e , —C(O)R d , —S(O) n R d , or —S(O) 2 NR a R b ; R d represents —C 1-6 alkyl; or a pharmaceutically acceptable salt or solvate thereof.